Viprosal B® (Viprosal B®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceCamphor + Salicylic acid + Turpentine gum + Poison adderCamphor + Salicylic acid + Turpentine gum + Poison adder
Similar drugsTo uncover
  • Alpipsal®
    ointment externally 
    ALTAYVITAMINS, CJSC     Russia
  • Viprosal B®
    ointment externally 
    GRINDEX, JSC     Latvia
    • Dosage form: & nbspointment for external use
    Composition:
    1 g of ointment contains:
    active ingredients: 0,05 MED (mouse units of action) venom of viper ordinary dry, 30 mg of racemic camphor, 30 mg of turpentine turpentine and 10 mg of salicylic acid;
    Excipients: vaseline, cetostearyl alcohol, paraffin, solid, sodium cetyl stearyl sulfate, glycerol, sodium chloride and purified water.
    Description:
    Ointment is white or white with a slightly yellowish hue of color, with a smell of camphor and turpentine.
    Pharmacotherapeutic group:Local irritant of natural origin
    ATX: & nbsp

    M.02.A.X   Other drugs for external use in pain syndrome with diseases of the musculoskeletal system

    Pharmacodynamics:
    An analgesic ointment with venom of a viper. Has a local irritating and analgesic effect. It causes irritation of sensitive receptors of the skin and subcutaneous tissue, dilates blood vessels, improves trophism of tissues.
    Indications:
    Neuralgia, arthralgia, myositis.
    Contraindications:
    Hypersensitivity to the components of the ointment, damage to the skin,skin diseases (including allergic and bacterial genesis), febrile conditions, pulmonary tuberculosis, cerebral and coronary circulation disorders, propensity to angiospasm, severe renal and hepatic impairment, general malnutrition.
    Children under 12 years.
    Pregnancy and lactation.
    Dosing and Administration:
    It is applied externally in adults and children over 12 years.
    Depending on the size of the cutaneous surface, 5-10 grams (1-2 teaspoons) of ointment are applied to the painful area in small portions and rubbed into the skin, depending on the intensity of the pain 1-2 times a day until the pain syndrome disappears. The duration of treatment depends on the nature and severity of the disease. If symptoms persist after 14 days of treatment, consult a doctor.
    Side effects:
    With increased sensitivity of the skin to the components of the ointment, itching, swelling or hives can occur.
    To avoid side effects, we recommend first applying a small amount of ointment to the skin to determine the sensitivity to the drug.
    If any side effects occur, consult a doctor.
    Overdose:Not noted.
    Interaction:Not known.
    Special instructions:
    If you accidentally swallow the ointment, consult a doctor.
    When accidentally ingested on mucous membranes, the ointment causes severe irritation. After applying the ointment, you should thoroughly wash your hands to avoid getting the ointment in the eyes and mucous membranes.
    If ointment enters the eyes and mucous membranes, rinse them thoroughly with water.
    Do not apply ointment to damaged skin.
    Form release / dosage:
    Ointment for external use.
    Packaging:
    30 g or 50 g in an aluminum tube with an inner surface lacquered, with a protective aluminum membrane on the neck and a cone-shaped device for puncturing the membrane in a screwed Bushon made of polyethylene or polypropylene. Tubu together with the instruction for medical use is placed in a pack of cardboard box.
    Storage conditions:
    Store at a temperature not exceeding 25 ° C. Do not store in the refrigerator and freezer.
    Keep out of the reach of children.
    Shelf life:
    3 years.
    Do not use after the expiry date printed on the package.
    Terms of leave from pharmacies:Without recipe
    Registration number:П N015169 / 01
    Date of registration:26.05.2009
    Expiration Date:Unlimited
    The owner of the registration certificate:GRINDEX, JSC GRINDEX, JSC Latvia
    Manufacturer: & nbsp
    Representation: & nbspGrindeks Rus, Open CompanyGrindeks Rus, Open CompanyRussia
    Information update date: & nbsp19.02.2017
    Illustrated instructions
      Instructions
      Up